| Figure 15. Gonorrhea — Positivity among 15-24 year old women tested in family planning clinics by state: United States and outlying areas, 2001 |
 |
*States reported gonorrhea positivity data on less than 500 women aged 15-24 years during 2001.
SOURCE: Regional Infertility Prevention Program; Office of Population Affairs; Local and State STD Control Programs; Centers for Disease Control and Prevention
|
| Figure 16. Gonococcal Isolate Surveillance Project
(GISP) — Location of participating clinics and regional laboratories:
United States, 2001 |
|
| Figure 17. Gonococcal Isolate Surveillance Project
(GISP) — Penicillin and tetracycline resistance among GISP isolates,
2001 |
 |
Note: PPNG=penicillinase-producing N. gonorrhoeae; TRNG=plasmid-mediated tetracycline resistant N. gonorrhoeae; PPNG-TRNG=plasmid-mediated penicillin and tetracycline resistant N. gonorrhoeae; PenR=chromosomally mediated penicillin resistant N. gonorrhoeae; TetR= chromosomally mediated tetracycline resistant N. gonorrhoeae; CMRNG=chromosomally mediated penicillin and tetracycline resistant N. gonorrhoeae.
|
| Figure 18. Gonococcal Isolate Surveillance Project
(GISP) — Percent of Neisseria gonorrhoeae isolates with resistance
or intermediate resistance to ciprofloxacin, 1990–2001 |
|
Note: Resistant isolates have ciprofloxacin MICs < 1
?g/mL. Isolates with intermediate resistance have ciprofloxacin
MICs of 0.125 - 0.5 ?g/mL. Susceptibility to ciprofloxacin was
first measured in GISP in 1990.
|
| Figure 19. Gonococcal Isolate Surveillance Project
(GISP) — Percent of men with gonorrhea who had a previous gonorrhea
infection, 1991–2001 |
 |
*Data first collected in 1991.
**Data first collected in 1992.
|
